Literature DB >> 8690519

Association of resistance-related protein expression with poor vascularization and low levels of oxygen in human rectal cancer.

J Mattern1, F Kallinowski, C Herfarth, M Volm.   

Abstract

Rectal carcinomas of previously untreated patients were analyzed for oxygen status using a computerized polarographic needle electrode histograph. Microvessel density and expression of c-jun, vascular endothelial growth factor (VEGF) and several resistance-related proteins (glutathione S-transferase-pi, GST; thymidylate synthase, TS; metallothioneine, MT) were determined using immunohistochemistry. To examine whether a relationship exists between intratumoral vessel density and tumor oxygenation, microvessel counts were determined in a 400x field using factor-VIII-related antigen and were correlated with the corresponding pO2 values. Linear regression analysis revealed a significant relationship between vessel density and oxygenation status of the tumors. Expression of c-jun, VEGF and resistance-related proteins was correlated with microvessel counts and pO2 values. Significantly lower vessel counts were found in GST- and MT-positive tumors and in tumors with overexpression of c-jun and VEGF than in negative tumors. In addition, significantly lower pO2 values were found in c-jun- and VEGF-positive tumors as well as a tendency for pO2 values to be lower in tumors where MT, GST and TS were expressed. These data show that expression of c-jun, VEGF, and resistance-related proteins is linked with poor vascularization and low oxygenation status in rectal cancer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8690519     DOI: 10.1002/(SICI)1097-0215(19960703)67:1<20::AID-IJC5>3.0.CO;2-1

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  12 in total

Review 1.  Angiogenesis: possibilities for therapeutic interventions.

Authors:  W Wynendaele; A T van Oosterom; A Pawinski; E A de Bruijn; R A Maes
Journal:  Pharm World Sci       Date:  1998-12

2.  Low hemoglobin is associated with increased serum levels of vascular endothelial growth factor (VEGF) in cancer patients. Does anemia stimulate angiogenesis?

Authors:  J Dunst; S Pigorsch; G Hänsgen; I Hintner; C Lautenschläger; A Becker
Journal:  Strahlenther Onkol       Date:  1999-03       Impact factor: 3.621

Review 3.  Evaluation of hypoxia with copper-labeled diacetyl-bis(N-methylthiosemicarbazone).

Authors:  Suzanne E Lapi; Jason S Lewis; Farrokh Dehdashti
Journal:  Semin Nucl Med       Date:  2015-03       Impact factor: 4.446

Review 4.  Defining normoxia, physoxia and hypoxia in tumours-implications for treatment response.

Authors:  S R McKeown
Journal:  Br J Radiol       Date:  2014-03       Impact factor: 3.039

5.  Correlation of P-glycoprotein expression with poor vascularization in human gallbladder carcinomas.

Authors:  Yu Tian; Li-Li Zhu; Ren-Xuan Guo; Chui-Feng Fan
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

Review 6.  Blood flow and oxygenation status of human tumors. Clinical investigations.

Authors:  H J Feldmann; M Molls; P Vaupel
Journal:  Strahlenther Onkol       Date:  1999-01       Impact factor: 3.621

7.  Role of oxygenation and vascularization in drug resistance.

Authors:  J Mattern; M Volm
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

8.  Hypoxia in head and neck squamous cell carcinoma.

Authors:  John Zenghong Li; Wei Gao; Jimmy Yu-Wai Chan; Wai-Kuen Ho; Thian-Sze Wong
Journal:  ISRN Otolaryngol       Date:  2012-10-16

9.  The constitutive level of vascular endothelial growth factor (VEGF) is more important than hypoxia-induced VEGF up-regulation in the angiogenesis of human melanoma xenografts.

Authors:  T Danielsen; E K Rofstad
Journal:  Br J Cancer       Date:  2000-05       Impact factor: 7.640

Review 10.  Oxygen-Based Nanocarriers to Modulate Tumor Hypoxia for Ameliorated Anti-Tumor Therapy: Fabrications, Properties, and Future Directions.

Authors:  Xianqiang Li; Yue Wu; Rui Zhang; Wei Bai; Tiantian Ye; Shujun Wang
Journal:  Front Mol Biosci       Date:  2021-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.